scholarly journals AGP in daily clinical practice: a guide for use with the FreeStyle Libre flash glucose monitoring system

2020 ◽  
Vol 20 (1) ◽  
pp. 32-40 ◽  
Author(s):  
Fraser W Gibb ◽  
Peter Jennings ◽  
Lalantha Leelarathna ◽  
Emma G Wilmot

As real-time continuous glucose monitoring and flash glucose monitoring systems become more widely prescribed in the daily management of diabetes, it is important that the ambulatory glucose profile (AGP) methodology for reviewing and interpreting trends in glucose control is effectively applied. In this article we look at the essential features of the AGP and provide systematic and practical guidance on how the AGP can be interpreted in daily diabetes care with confidence. Using examples taken from glucose data captured by the FreeStyle Libre flash glucose monitoring system, we show how each aspect of the AGP can be used to understand daily patterns in glucose control for a person with diabetes, including the importance of time in range and adjunct use of individual daily logs. Using these elements collectively, we show how and why treatment adjustments can be made, with the goal of improving glycaemic control and diabetes outcomes.

2021 ◽  
Author(s):  
María‐Elena Gatica‐Ortega ◽  
María‐Antonia Pastor‐Nieto ◽  
Rafaela Torres‐Aranda ◽  
Loreto Luna‐Bastante ◽  
Cristina Pérez‐Hortet

2020 ◽  
pp. 1098612X2096501
Author(s):  
Adam M Shoelson ◽  
Orla M Mahony ◽  
Michelle Pavlick

Objectives Glucose monitoring is an integral part of diabetes management. Interstitial glucose monitoring systems are increasingly commonly being used for this purpose in dogs and cats, including the use of a flash glucose monitoring system (FGMS). The aim of this study was to describe the incidence and nature of complications associated with the use of an FGMS in diabetic cats. Methods The medical records of all cats that had placement of a 14-day FGMS during a 1-year period were retrospectively reviewed. Data retrieved included the number of days the sensor remained attached and functional, location of sensor placement and complications associated with the sensor. Complications were defined as early sensor detachment, sensor failure prior to the end of the 14-day monitoring period and dermatologic changes at the sensor site. Descriptive statistics were used to characterize the data. Results Twenty cats had a total of 33 FGMSs placed. The majority (30/33 [91%]) of sensors were placed over the dorsolateral aspect of the thorax just caudal to the scapula. Twenty (61%) FGMSs remained attached and functional for the full 14 days. The overall incidence of complications associated with FGMS use was 10/33 (30%). The most frequent complication was early sensor detachment (n = 5/33 [15%]). Mild dermatologic changes (erythema, crusts) were noted with 4/33 (12%) FGMSs. More serious complications (skin erosions, abscess formation) were noted with 2/33 (6%) FGMSs. Conclusions and relevance The use of the FGMS is relatively safe in cats, although there are potential complications that owners should be made aware of.


Sign in / Sign up

Export Citation Format

Share Document